IRIS
DI MARO, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.879
NA - Nord America 2.197
AS - Asia 1.908
SA - Sud America 337
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 9.354
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.195
US - Stati Uniti d'America 2.124
SG - Singapore 608
IT - Italia 581
CN - Cina 448
IE - Irlanda 400
BR - Brasile 290
HK - Hong Kong 290
VN - Vietnam 250
GB - Regno Unito 195
DE - Germania 137
UA - Ucraina 117
IN - India 104
KR - Corea 72
CA - Canada 47
TR - Turchia 46
FI - Finlandia 44
SE - Svezia 36
GR - Grecia 30
FR - Francia 29
NL - Olanda 28
ES - Italia 23
AR - Argentina 20
MX - Messico 19
PK - Pakistan 18
BD - Bangladesh 17
AT - Austria 15
BE - Belgio 13
DK - Danimarca 13
JP - Giappone 13
EC - Ecuador 9
IQ - Iraq 8
PL - Polonia 8
VE - Venezuela 8
ZA - Sudafrica 6
MA - Marocco 5
UZ - Uzbekistan 5
ID - Indonesia 4
CL - Cile 3
CO - Colombia 3
CR - Costa Rica 3
DZ - Algeria 3
IR - Iran 3
KE - Kenya 3
LK - Sri Lanka 3
PE - Perù 3
PT - Portogallo 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
CH - Svizzera 2
EG - Egitto 2
EU - Europa 2
HN - Honduras 2
IL - Israele 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BW - Botswana 1
CG - Congo 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
ML - Mali 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 9.354
Salva come PNG Salva come JPEG
Città #
Moscow 1.173
Dublin 400
Singapore 306
Hong Kong 289
Chandler 268
Santa Clara 261
San Jose 249
Jacksonville 193
The Dalles 126
Ashburn 111
Ho Chi Minh City 106
Beijing 77
Bengaluru 72
Seoul 72
Hefei 70
Ann Arbor 67
Naples 57
Aversa 56
Princeton 53
London 49
Medford 46
Hanoi 45
Roxbury 42
Chicago 39
Munich 39
Bremen 38
Napoli 37
Caserta 32
Elora 31
São Paulo 27
Istanbul 26
Dallas 24
Los Angeles 24
New York 23
Rome 20
Des Moines 18
Barcelona 17
Boardman 16
Milan 16
Viterbo 15
Wilmington 15
Turku 14
Afragola 12
Brussels 12
Cesano Maderno 12
Woodbridge 12
Boydton 11
Copenhagen 11
San Mateo 11
Lahore 10
Mumbai 10
Amsterdam 9
Belo Horizonte 9
Biên Hòa 9
Cambridge 9
Da Nang 9
Mexico City 9
Haiphong 8
Mountain View 8
Vienna 8
Brasília 7
Casal di Principe 7
Helsinki 7
Marcianise 7
Montreal 7
Piscataway 7
Salvador 7
Thái Bình 7
Tokyo 7
Brooklyn 6
Falkenstein 6
Florence 6
Houston 6
Jinan 6
Nanjing 6
Nuremberg 6
Orem 6
Rio de Janeiro 6
Salerno 6
Volla 6
Bologna 5
Lanzhou 5
Memphis 5
Ninh Bình 5
Norwalk 5
Notre Dame 5
Phoenix 5
San Felice A Cancello 5
San Francisco 5
Tashkent 5
Tianjin 5
Warsaw 5
Auburn Hills 4
Baghdad 4
Boltiere 4
Bragança Paulista 4
Charlotte 4
Chennai 4
Council Bluffs 4
Hortolândia 4
Totale 5.059
Salva come PNG Salva come JPEG
Nome #
Antioxidant peptides from "Mozzarella di Bufala Campana DOP" after simulated gastrointestinal digestion: In vitro intestinal protection, bioavailability, and anti-haemolytic capacity 218
Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomers 200
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells 192
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists 184
Carprofen Analogues as Sirtuin Inhibitors: Enzyme and Cellular Studies 179
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer 173
Switchable Protecting Strategy for Solid Phase Synthesis of DNA and RNA Interacting Nucleopeptides 166
Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides 165
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication 164
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells 161
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells 161
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence 157
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites 153
Benzofuroxane derivatives as multi-effective agents for the treatment of cardiovascular diabetic complications. Synthesis, functional evaluation, and molecular modeling studies 153
Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents 153
Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer 151
Disulfide Bond Replacement with 1,4- and 1,5-Disubstituted [1,2,3]-Triazole on C-X-C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences 151
Ultrasound-assisted Peptide Nucleic Acids synthesis (US-PNAS) 147
Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors 146
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 145
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists 142
A novel smaller β-defensin-derived peptide is active against multidrug-resistant bacterial strains 142
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification 140
3-Aryl-[1,2,4]triazino[4,3-a ]benzimidazol-4(10 H)-one: A novel template for the design of highly selective A2B adenosine receptor antagonists 140
Pharmacological folding chaperones act as allosteric ligands of Frizzled4 139
Discovery of N-Substituted-2-Oxoindolin Benzoylhydrazines as c-MET/SMO Modulators in EGFRi-Resistant Non-Small Cell Lung Cancer 138
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells 138
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer 137
Efficient Solid-Phase Synthesis of FK228 Analogues as Potent Antitumoral Agents 136
Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6-Selective Integrin Ligands 134
Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme 133
Click-chemistry (CuAAC) trimerization of an αvβ6-integrin targeting Ga-68-peptide: Enhanced contrast for in-vivo PET imaging of human lung adenocarcinoma xenografts 133
β-Cyclodextrin Inclusion Complexes with Model Pentapeptides: Role of the Tyrosine Position within the Peptide Chain. 132
Properly Substituted Analogues of BIX-01294 Lose Inhibition of G9a Histone Methyltransferase and Gain Selective Anti-DNA Methyltransferase 3A Activity 132
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas 132
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 132
The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins 132
The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines 131
From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment 128
Water-soluble pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as human A 3 adenosine receptor antagonists 128
Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening 128
Halting the Spread of Herpes Simplex Virus-1: The Discovery of an Effective Dual αvβ6/αvβ8 Integrin Ligand 128
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 127
Streamlining Large Chemical Library Docking with Artificial Intelligence: the PyRMD2Dock Approach 126
From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands 126
Intestinal anti-inflammatory effect of a peptide derived from gastrointestinal digestion of buffalo (Bubalus bubalis) mozzarella cheese 126
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients 123
Discovering Dually Active Anti-cancer Compounds with a Hybrid AI-structure-based Approach 122
Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide 121
Shading the TRF2 Recruiting Function: A New Horizon in Drug Development 116
Development of an efficient solid-phase synthetic methodology to construct a combinatorial library of a potent HDAC inhibitor. 116
Investigation of the Stereochemical-Dependent DNA and RNA Binding of Arginine-Based Nucleopeptides 116
Sustainable Ultrasound-Assisted Solid-Phase peptide synthesis (SUS-SPPS): Less Waste, more efficiency 115
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells 114
Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment 111
New 2-Heterocyclyl-imidazo[2,1-i]purin-5-one Derivatives as Potent and Selective Human A(3) Adenosine Receptor Antagonists 111
Paper-based electrochemical device for early detection of integrin αvβ6 expressing tumors 110
SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage 110
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells 109
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase 109
Progresses in the pursuit of aldose reductase inhibitors: The structure-based lead optimization step 106
FK228 analogues induce fetal hemoglobin in human erythroid progenitors 105
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 102
Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands 100
Novel alpha-MSH Peptide Analogues with Broad Spectrum Antimicrobial Activity 97
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 94
Neuropeptide S receptor ligands: a patent review (2005-2016) 91
Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures. 90
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment 90
The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells 89
Reaction between (Z)-Arylchlorooximes and α-Isocyanoacetamides: A procedure for the synthesis of Aryl-α-ketoamide amides 87
Cigarette smoke destabilizes G-quadruplex structures and antagonizes G4-ligand effects in macrophages 43
Targeting Staphylococcus aureus with potent de novo-designed proline-core short antimicrobial lipopeptides 18
PyRMD Studio: A Unified Suite for Next-Generation, AI-Powered Virtual Screening 17
Probing Guanidino Pendant or Bridged Groups in Cyclic Antimicrobial Peptides Derived from Temporin L: A Strategy to Improve Efficacy against Gram-Negative Bacteria 16
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy 13
Development of Novel Proline- and Pipecolic Acid-Based Allosteric Inhibitors of Dengue and Zika Virus NS2B/NS3 Protease 12
Totale 9.552
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.748
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022403 23 10 7 7 108 12 9 20 17 59 31 100
2022/2023955 119 19 30 80 115 83 3 58 406 10 17 15
2023/2024392 50 11 28 25 92 39 6 20 2 3 34 82
2024/20251.399 15 16 18 47 209 154 155 113 269 171 107 125
2025/20265.461 179 304 279 292 473 2.960 190 268 206 146 107 57
2026/202722 22 0 0 0 0 0 0 0 0 0 0 0
Totale 9.552